These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4719 related articles for article (PubMed ID: 6546203)

  • 1. The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.
    Boeryd B; Benktson A
    Clin Exp Metastasis; 1983; 1(3):289-95. PubMed ID: 6546203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized study of adjuvant immunotherapy with levamisole and Corynebacterium parvum in operable non-small cell lung cancer.
    Fox RM; Woods RL; Tattersall MH; Basten A
    Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1043-5. PubMed ID: 6998933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy].
    Bianucci P; Pastorino G
    Arch Sci Med (Torino); 1980; 137(1):33-40. PubMed ID: 7458652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
    El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
    Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo.
    Bowlin TL; Rosenberger AL; Sunkara PS
    Cancer Immunol Immunother; 1985; 20(3):214-8. PubMed ID: 3933819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE; Sadler TE; Jones PD
    Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy.
    Gatenby PA; Basten A; Tattersall MH; Fox RM
    Lancet; 1980 May; 1(8177):1082. PubMed ID: 6103412
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases.
    Proctor JW; Auclair BG; Stokowski L; Mansell WA; Shibata H
    Eur J Cancer (1965); 1977 Feb; 13(2):115-22. PubMed ID: 852486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
    Pot-Deprun J; Chouroulinkov I
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of nonspecific immunotherapy on the course of murine melanoma.
    Woods JE; Ritts RE
    J Surg Oncol; 1977; 9(1):15-20. PubMed ID: 839793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages.
    Calorini L; Mannini A; Bianchini F; Mugnai G; Balzi M; Becciolini A; Ruggieri S
    Clin Exp Metastasis; 1999; 17(10):889-95. PubMed ID: 11089888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of non-specific immunopotentiators in experimental Trypanosoma cruzi infection.
    Abath FG; Coutinho EM; Montenegro SM; Gomes YM; Carvalho AB
    Trans R Soc Trop Med Hyg; 1988; 82(1):73-6. PubMed ID: 2459820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimetastatic effect of cell-wall skeleton of Propionibacterium acnes C7 on Lewis lung carcinoma in C57BL/6J mice.
    Tanio Y; Yamamura Y; Saiki I; Okumura H; Kamisango K; Okuyama H; Azuma I
    Gan; 1981 Jun; 72(3):403-10. PubMed ID: 7319198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
    Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
    Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Corynebacterium parvum and cortisone on the primary Lewis tumour and its metastases.
    Jones PD; Sadler TE; Castro JE
    Int J Cancer; 1978 Jun; 21(6):784-8. PubMed ID: 669856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases.
    Sadler TE; Castro JE
    Br J Surg; 1976 Apr; 63(4):292-6. PubMed ID: 1276661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 236.